Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-075562
Filing Date
2014-12-15
Accepted
2014-12-15 21:01:24
Documents
2
Period of Report
2014-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3965
2 POA DOCUMENT poa.txt EX-24.4_549809 2600
  Complete submission text file 0001209191-14-075562.txt   8113
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9360 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Business Address
Marshall Paul (Reporting) CIK: 0001383994 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33221 | Film No.: 141288201